The effect of coccidiostatics on Toxoplasma gondii infections of mice.
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D002224:Carbanilides / Q000627:therapeutic use; D002264:Carboxylic Acids / Q000627:therapeutic use; D002722:Chlorobenzenes / Q000627:therapeutic use; D004987:Ethers / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D051379:Mice; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy*
D000981:Antiprotozoal Agents; D001593:Benzyl Compounds; D002224:Carbanilides; D002264:Carboxylic Acids; D002722:Chlorobenzenes; D004987:Ethers; D006146:Guanidines; D011725:Pyridines; D011743:Pyrimidines; D011804:Quinolines